Showing results (671-680 of 14,087) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.Gynecologic Oncology|July 1, 1990
A pilot study investigating intraoperative electron beam irradiation in the treatment of ovarian malignanciesA A Konski, J Neisler, G Phibbs, et al.Gynecologic Oncology|May 1, 1990
Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyS C Plaxe, P R Dottino, H M Goodman, et al.Gynecologic Oncology|April 13, 2011
Patterns of spread and recurrence of sex cord-stromal tumors of the ovaryMelissa M Thrall, Pamela Paley, Ellen Pizer, et al.Gynecologic Oncology|May 3, 2011
MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2Qiuhua Wu, Rongjiao Guo, Min Lin, et al.Gynecologic Oncology|April 20, 2011
Paget's disease of the vulva: Diagnosis and follow-up key to management; a retrospective study of 50 cases from QueenslandIan S C Jones, Alex Crandon, Karen SandayGynecologic Oncology|June 29, 2011
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerCharlotte H Clarke, Christine Yip, Donna Badgwell, et al.Gynecologic Oncology|July 8, 2011
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study GroupK Baumann, J Pfisterer, P Wimberger, et al.Gynecologic Oncology|July 23, 2011
Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational studyS Zahra, J A M Anderson, D Stirling, et al.Gynecologic Oncology|July 19, 2011
Oncolytic virotherapy of breast cancerAndreas D Hartkopf, Tanja Fehm, Diethelm Wallwiener, et al.Pageof 1,409